IGF-1 LR3 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of IGF-1 LR3 is 20-30 hours (vs. ~15 minutes for native IGF-1). This means dosing once daily, typically post-workout is typical to maintain stable levels. The half-life directly affects how long IGF-1 LR3 remains active and influences optimal injection timing.
What Is the Half-Life of IGF-1 LR3?
The half-life of IGF-1 LR3 is 20-30 hours (vs. ~15 minutes for native IGF-1). This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer IGF-1 LR3 to maintain therapeutic blood levels.
What Does IGF-1 LR3's Half-Life Mean for Dosing?
With a half-life of 20-30 hours (vs. ~15 minutes for native IGF-1), IGF-1 LR3 requires dosing once daily, typically post-workout to maintain stable levels. The standard dosage of 20-100 mcg daily; conservative protocols use 20-40 mcg via subcutaneous injection (intramuscular for localized effect) accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, IGF-1 LR3 reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For IGF-1 LR3, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject IGF-1 LR3?
Optimal timing depends on your research goals. A half-life of 20-30 hours (vs. ~15 minutes for native IGF-1) means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (once daily, typically post-workout) for more stable levels throughout the day.
How Does IGF-1 LR3's Half-Life Compare to Similar Peptides?
IGF-1 LR3 is a Growth factor analog, IGF-1 receptor agonist. Its half-life of 20-30 hours (vs. ~15 minutes for native IGF-1) positions it with a shorter duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your IGF-1 LR3 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for IGF-1 LR3.
Open Calculator →Bottom Line: IGF-1 LR3 Half-Life and Dosing
IGF-1 LR3 has a half-life of 20-30 hours (vs. ~15 minutes for native IGF-1), supporting the standard protocol of 20-100 mcg daily; conservative protocols use 20-40 mcg dosed once daily, typically post-workout over 4-8 weeks maximum to prevent receptor desensitization and insulin resistance.
Read our IGF-1 LR3 dosage guide for complete protocol details.
Complete Guide
IGF-1 LR3 : Dosing, Mechanisms & Research
Related Reading
- IGF-1 LR3 Dosage Guide
- IGF-1 LR3 Benefits
- IGF-1 LR3 Side Effects
- IGF-1 LR3 Stacking Guide
- IGF-1 LR3 Cycle Guide
- IGF-1 LR3 Research
Research-Grade Sourcing
If you're going to research IGF-1 LR3, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is IGF-1 LR3?
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arginine 3) is a Growth factor analog, IGF-1 receptor agonist. Synthetic analog of endogenous IGF-1 with arginine extension and leucine substitution increasing half-life 20-30x over native IGF-1. It is researched for rapid muscle growth, accelerated recovery, bone density increase, tendon healing, neurological protection, localized anabolic effect at injection site.
What is the recommended IGF-1 LR3 dosage?
Common dosages: 20-100 mcg daily; conservative protocols use 20-40 mcg administered once daily, typically post-workout via subcutaneous injection (intramuscular for localized effect). Cycle length: 4-8 weeks maximum to prevent receptor desensitization and insulin resistance. Half-life: 20-30 hours (vs. ~15 minutes for native IGF-1). Use our peptide calculator for exact reconstitution math.
What are the side effects of IGF-1 LR3?
Hypoglycemia is the most critical risk (shakiness, sweating, confusion, potential loss of consciousness). Insulin resistance with prolonged use. Fluid retention, headaches, joint stiffness, carpal tunnel syndrome. Theoretical cancer risk through mitogenic effects at supraphysiological doses. Acromegalic changes possible with chronic abuse.
Is IGF-1 LR3 safe?
IGF-1 LR3 has shown a preliminary safety profile in research. Not FDA-approved. WADA prohibited at all times with no Therapeutic Use Exemption pathway. Classified as research reagent. All research should follow appropriate safety protocols.